MY129927A - Imidazoidolizine derivatives and process for preparation thereof. - Google Patents

Imidazoidolizine derivatives and process for preparation thereof.

Info

Publication number
MY129927A
MY129927A MYPI92001597A MYPI9201597A MY129927A MY 129927 A MY129927 A MY 129927A MY PI92001597 A MYPI92001597 A MY PI92001597A MY PI9201597 A MYPI9201597 A MY PI9201597A MY 129927 A MY129927 A MY 129927A
Authority
MY
Malaysia
Prior art keywords
substituted
preparation
derivatives
pharmaceutically acceptable
imidazoindolizine
Prior art date
Application number
MYPI92001597A
Inventor
Yasushi Honma
Yasuo Sekine
Sumihiro Nomura
Kazuaki Naito
Hiroshi Narita
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of MY129927A publication Critical patent/MY129927A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Abstract

AN IMIDAZOINDOLIZINE DERIVATIVE OF THE FORMULA [I]: WHEREIN RL IS LOWER ALKYL, R2 IS HYDROGEN, CYANO, LOWER ALKYL, LOWER ALKANOYL, LOWER ALKOXYCARBONYL, PHENYL-LOWER ALKOXYCARBONYL, LOWER ALKYLSULFONYL, SUBSTITUTED OR UNSUBSTITUTED PHENYL, ARYLCARBONYL, OR 5- OR 6-MEMBERED NITROGEN-CONTAINING HETEROMONOCYCLIC GROUP-SUBSTITUTED CARBONYL, RING A IS SUBSTITUTED OR UNSUBSTITUTED PHENYL, AND M IS 0 OR 1, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PROCESS FOR PREPARATION THEREOF, SAID IMIDAZOINDOLIZINE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF SHOW EXCELLENT ANGIOTENSIN II INHIBITORY ACTIVITIES AND ARE USEFUL IN THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION.
MYPI92001597A 1991-09-10 1992-09-07 Imidazoidolizine derivatives and process for preparation thereof. MY129927A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30856091 1991-09-10
JP5304492 1992-01-27

Publications (1)

Publication Number Publication Date
MY129927A true MY129927A (en) 2007-05-31

Family

ID=26393753

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92001597A MY129927A (en) 1991-09-10 1992-09-07 Imidazoidolizine derivatives and process for preparation thereof.

Country Status (16)

Country Link
US (1) US5268377A (en)
EP (1) EP0531876B1 (en)
JP (1) JP2590797B2 (en)
KR (1) KR0168457B1 (en)
AT (1) ATE146474T1 (en)
AU (1) AU644539B2 (en)
CA (1) CA2077420C (en)
DE (1) DE69216013T2 (en)
DK (1) DK0531876T3 (en)
ES (1) ES2098403T3 (en)
FI (1) FI98369C (en)
GR (1) GR3022106T3 (en)
ID (1) ID902B (en)
IL (1) IL103021A (en)
MY (1) MY129927A (en)
SG (1) SG42962A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06271576A (en) * 1993-03-19 1994-09-27 Upjohn Co:The Manufacturing of imidazole derivative
FR2712592B1 (en) * 1993-11-17 1995-12-22 Adir New nitrogenous tricyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011522828A (en) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
KR102538999B1 (en) 2016-06-29 2023-05-31 유니버시떼 드 몬트리얼 biarylmethyl heterocycle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1047148A1 (en) * 1981-03-30 1986-12-23 Институт физико-органической химии и углехимии АН УССР Benzylidene-derivatives of imidazo-/4,5-g/-indolysines possessing bacteriostatic and fungistatic activity
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
US4816463A (en) * 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3928177A1 (en) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K BENZIMIDAZOLE, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
FI98369B (en) 1997-02-28
GR3022106T3 (en) 1997-03-31
AU644539B2 (en) 1993-12-09
DE69216013D1 (en) 1997-01-30
ES2098403T3 (en) 1997-05-01
EP0531876B1 (en) 1996-12-18
KR930006024A (en) 1993-04-20
FI98369C (en) 1997-06-10
US5268377A (en) 1993-12-07
JP2590797B2 (en) 1997-03-12
ID902B (en) 1996-09-09
AU2205692A (en) 1993-03-11
CA2077420C (en) 1998-08-25
JPH05279365A (en) 1993-10-26
DE69216013T2 (en) 1997-05-07
KR0168457B1 (en) 1999-01-15
IL103021A (en) 1996-10-16
IL103021A0 (en) 1993-02-21
FI924043A (en) 1993-03-11
SG42962A1 (en) 1997-10-17
DK0531876T3 (en) 1997-02-17
CA2077420A1 (en) 1993-03-11
FI924043A0 (en) 1992-09-10
EP0531876A3 (en) 1993-05-05
ATE146474T1 (en) 1997-01-15
EP0531876A2 (en) 1993-03-17

Similar Documents

Publication Publication Date Title
NZ514873A (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
MY129927A (en) Imidazoidolizine derivatives and process for preparation thereof.
WO2001038324A3 (en) Imidazole derivatives and their use as raf kinase inhibitors
MX9800946A (en) 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors.
YU69902A (en) New piperazine derivatives
MY123528A (en) Aromatic nitrogen-containing 6-membered cyclic compounds.
BG103195A (en) Substituted indazole derivatives and their application as inhibitors of phosphodiesterase (pde) type iv and of the production of a tumournecrotic factor (tnf)
EP0638560A4 (en) Remedy for osteoporosis and diazepine compound.
MXPA05012415A (en) Isoquinoline derivatives and their use as gfat inhibitors.
EA004302B9 (en) β-CARBOLINE DRUG PRODUCTS
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
AU4205197A (en) New thiazole derivatives with phosphodiesterase-inhibiting effect
CA2244777A1 (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
CA2077419A1 (en) Imidazopyridine derivatives and process for preparation thereof
CA2084163A1 (en) Endothelin antagonistic substance
MX9709466A (en) Methods of inhibiting melanoma.
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
AP9400638A0 (en) Water soluble derivatives of camptothecin.
AP2002002595A0 (en) Heterocyclic amide derivatives.
AU3402701A (en) TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme
DE69726437D1 (en) BENZOTHIOPHENE DERIVATIVES, THEIR PRODUCTION AND USE AS UROKINASE INHIBITORS
PL324086A1 (en) Antagonists of calcium passages
MX9605604A (en) New agonist compounds.
GEP20012417B (en) Indole Derivatives, Their Salts, Solvates and Physiologically Functional Derivatives, Method for Its Production, Therapeutic Compounds and Method for Their Preparation